Does aortic root blood flow increase after pancuronium in neonates with hyaline membrane disease?
Pancuronium bromide may have a direct beneficial effect on the circulation of preterm infants with hyaline membrane disease.
RVMSP provides a better clinical utility, compared with RVAP, in patients with high-degree atrioventricular block and moderately depressed LV function whose LVEF levels ranged from 35% to 40%.